A single-dose vaccine protects nearly 80% of people not previously infected with dengue, according to researchers from the Butantan Institute in Brazil. Results from a Phase 3 clinical trial show that ...

Additional data show a booster increases protection 94 percent protection in the U.S. with booster given at two months Four-fold increase in antibodies when given at two months 12-fold increase in ...

With its ease of configuration and its comprehensive range of facilities, including a variable-frequency voltage source with a continuous phase-shift function, Megger’s new self-contained SVERKER 780 ...